As of August 29, 2026, Cytokinetics's top three insider holders are Robert I Blum (President Ceo, 377.82K shares), Fady Ibraham Malik (Evp Research Development, 153.90K shares), David Cragg (Chief Hr Admin Officer, 153.23K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Robert I Blum | President Ceo | 377,820 | 0 | 377,820 | 25.3% | 31 Aug, 2026 |
| 2 | Fady Ibraham Malik | Evp Research Development | 153,902 | 0 | 153,902 | 10.3% | 18 Aug, 2026 |
| 3 | David Cragg | Chief Hr Admin Officer | 153,233 | 0 | 153,233 | 10.3% | 08 Mar, 2022 |
| 4 | Jeffrey Hessekiel | Chief Legal Admin Officer | 107,943 | 0 | 107,943 | 7.2% | 17 Mar, 2026 |
| 5 | Mark A Schlossberg | Svp Legal General Counsel | 103,408 | 0 | 103,408 | 6.9% | 15 Mar, 2022 |
| 6 | Ching Jaw | Svp Finance Cfo | 87,346 | 0 | 87,346 | 5.8% | 07 Mar, 2023 |
| 7 | John T Henderson | Director | 78,360 | 0 | 78,360 | 5.2% | 16 Jul, 2026 |
| 8 | Sung Lee | Evp, Chief Financial Officer | 63,221 | 0 | 63,221 | 4.2% | 02 Jul, 2026 |
| 9 | Andrew Callos | Evp, Chief Commercial Officer | 58,555 | 0 | 58,555 | 3.9% | 31 Aug, 2026 |
| 10 | Wendell Wierenga | Director | 35,563 | 0 | 35,563 | 2.4% | 16 Jul, 2026 |
| 11 | Nancy Wysenski | Director | 33,992 | 0 | 33,992 | 2.3% | 16 Jul, 2026 |
| 12 | Brett A Pletcher | Evp, Chief Legal Officer | 33,140 | 0 | 33,140 | 2.2% | 03 Sep, 2024 |
| 13 | Wendall Wierenga | Director | 32,345 | 0 | 32,345 | 2.2% | 16 Jul, 2025 |
| 14 | L Patrick Gage | Director | 28,932 | 0 | 28,932 | 1.9% | 08 Nov, 2021 |
| 15 | Muna Bhanji | Director | 26,361 | 0 | 26,361 | 1.8% | 27 May, 2026 |
| 16 | Robert Arthur Harrington | Director | 21,932 | 0 | 21,932 | 1.5% | 16 Jul, 2026 |
| 17 | Santo J Costa | Director | 20,600 | 0 | 20,600 | 1.4% | 16 May, 2024 |
| 18 | Sandford D Smith | Director | 18,801 | 0 | 18,801 | 1.3% | 03 Jan, 2024 |
| 19 | Robert Wong | Vp, Chief Accounting Officer | 18,655 | 0 | 18,655 | 1.2% | 05 Dec, 2024 |
| 20 | B Lynne Parshall | Director | 10,784 | 0 | 10,784 | 0.7% | 01 Sep, 2026 |
| 21 | Edward M. Md Kaye | Director | 10,434 | 0 | 10,434 | 0.7% | 16 Jul, 2026 |
| 22 | Robert E Landry | Director | 10,184 | 0 | 10,184 | 0.7% | 27 May, 2026 |
| 23 | Robert Califf | Director | 6,003 | 0 | 6,003 | 0.4% | 04 Jan, 2022 |
| 24 | James M Daly | Director | 3,390 | 0 | 3,390 | 0.2% | 16 Jul, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 01 Sep, 2026 | B Lynne Parshall | Director | Disposed S | 5,000 | $71.48 | $357.40K | 10,784 | Direct |
| 31 Aug, 2026 | Robert I Blum | President Ceo | Acquired M | 7,500 | $10.60 | $79.50K | 385,320 | Direct |
| 31 Aug, 2026 | Andrew Callos | Evp, Chief Commercial Officer | Acquired M | 10,000 | $23.26 | $232.60K | 68,555 | Direct |
| 31 Aug, 2026 | Robert I Blum | President Ceo | Disposed S | 7,500 | $70.24 | $526.80K | 377,820 | Direct |
| 31 Aug, 2026 | Andrew Callos | Evp, Chief Commercial Officer | Disposed S | 10,000 | $70.24 | $702.40K | 58,555 | Direct |
| 31 Aug, 2026 | Andrew Callos | Evp, Chief Commercial Officer | Disposed M | 10,000 | $0.00 | $0 | 0 | Direct |
| 31 Aug, 2026 | Robert I Blum | President Ceo | Disposed M | 7,500 | $0.00 | $0 | 164,245 | Direct |
| 18 Aug, 2026 | Fady Ibraham Malik | Evp Research Development | Acquired M | 3,500 | $7.80 | $27.30K | 157,402 | Direct |
| 18 Aug, 2026 | Fady Ibraham Malik | Evp Research Development | Disposed S | 3,500 | $75.82 | $265.37K | 153,902 | Direct |
| 18 Aug, 2026 | Fady Ibraham Malik | Evp Research Development | Disposed M | 3,500 | $0.00 | $0 | 30,386 | Direct |
| 10 Aug, 2026 | Robert I Blum | President Ceo | Acquired M | 7,500 | $10.60 | $79.50K | 385,320 | Direct |
| 10 Aug, 2026 | Robert I Blum | President Ceo | Disposed S | 7,500 | $76.76 | $575.70K | 377,820 | Direct |
| 10 Aug, 2026 | Robert I Blum | President Ceo | Disposed M | 7,500 | $0.00 | $0 | 171,745 | Direct |
| 30 Jul, 2026 | Andrew Callos | Evp, Chief Commercial Officer | Acquired M | 14,000 | $23.26 | $325.64K | 72,555 | Direct |
| 30 Jul, 2026 | Andrew Callos | Evp, Chief Commercial Officer | Disposed S | 14,000 | $79.88 | $1.12Mn | 58,555 | Direct |
| 30 Jul, 2026 | Andrew Callos | Evp, Chief Commercial Officer | Disposed M | 14,000 | $0.00 | $0 | 10,000 | Direct |
| 27 Jul, 2026 | Robert I Blum | President Ceo | Acquired M | 7,500 | $10.60 | $79.50K | 385,320 | Direct |
| 27 Jul, 2026 | Robert I Blum | President Ceo | Disposed S | 7,500 | $80.87 | $606.53K | 377,820 | Direct |
| 27 Jul, 2026 | Robert I Blum | President Ceo | Disposed M | 7,500 | $0.00 | $0 | 179,245 | Direct |
| 21 Jul, 2026 | Fady Ibraham Malik | Evp Research Development | Acquired M | 3,500 | $7.80 | $27.30K | 157,402 | Direct |